michael enxing  nevro corp  zoominfocom   vertiflex inc appoints michael enxing to vice president chief commercial officer  business wire vertiflex inc appoints michael enxing to vice president chief commercial officer july    am eastern daylight time carlsbad califbusiness wirevertiflex inc a leading innovator of advanced minimally invasive interventions for spinal stenosis today announced the appointment of michael enxing as vice president and chief commercial officer mr enxing will be responsible for leading all aspects of the company’s sales marketing health economicsreimbursement and professional education strategies related to the already successful launch of the superion® indirect decompression system for the treatment of lumbar spinal stenosis mr enxing brings over  years of successful global leadership experience in product commercialization in the medical device spinal and chronic pain fields most recently michael served as vice president of sales at nevro corporation where he led the company to impressive growth both internationally and domestically over the previous four years prior to nevro he served as vice president of sales and marketing for vertos medical and has held various executive positions at cardiovascular systems inc fka cardio vascular solutions csi advanced neuromodulation systems inc acquired by st jude medical inc stryker corporation and tecnol medical products inc acquired by kimberly clark  michael is a graduate of iowa state university with a bs in communications and focus in business administration earl r fender president  chief executive officer of vertiflex said “we are very pleased to have attracted an executive of michael’s caliber into our organization michael is a visionary leader who understands sales and marketing execution market dynamics critical organizational metrics and cultural drivers that deliver team success and ensures the best customer engagement experiences possible we are confident that michael’s track record of significantly scaling businesses will add considerable value to vertiflex our investors physician providers and most of all to patients who will benefit from superion’s demonstrated and durable clinical and safety profile” mr enxing said “i’m proud to join the vertiflex team as a result of the company’s achievements in product development level i clinical evidence generation earning a pma approval and category i reimbursement for superion the stage is set to build a large high growth new category in spine that is focused on compelling clinical outcomes for patients and their physicians based on my prior experience in commercializing an early generation product for lumbar spinal stenosis i believe superion having significant published peerreviewed data is positioned as the bestinclass minimally invasive solution for lumbar spinal stenosis that will also compare well to open surgical decompression in treating patients suffering from lss” about vertiflex vertiflex is a privately held medical device company dedicated to the advancement of minimally invasive solutions for the treatment of lumbar spinal stenosis which is the leading cause of spinal surgery in the elderly founded in  and headquartered in carlsbad ca vertiflex has developed proprietary minimally invasive technologies for performing both indirect and direct decompressions of the lumbar spine these procedures fill the gap in the stenosis treatment continuum between conservative care and traditional spine surgery to date vertiflex has compiled the largest most rigorous body of device clinical evidence related to lumbar spinal stenosis for more information visit wwwvertiflexspinecom contacts vertiflex inckathryn larson  9infovertiflexspinecom release summary vertiflex a leading innovator of advanced minimally invasive interventions for spinal stenosis announced the appointment of michael enxing as cco hashtags vertiflex superion social media profiles vertiflex on facebook vertiflex on twitter vertilfex on linked in vertiflex on google vertiflex on instagram contacts vertiflex inckathryn larson  9infovertiflexspinecom search advanced news search advanced news search log in sign up vertiflex appoints michael enxing to vice president chief commercial officer employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       vertiflex appoints michael enxing to vice president chief commercial officer tweet   am   life sciences jobs     bullet newest jobs  last  hours   bullet california jobs   bullet massachusetts jobs   bullet new jersey jobs   bullet maryland jobs   bullet washington jobs   view more jobs carlsbad califbusiness wirevertiflex inc a leading innovator of advanced minimally invasive interventions for spinal stenosis today announced the appointment of michael enxing as vice president and chief commercial officer mr enxing will be responsible for leading all aspects of the company’s sales marketing health economicsreimbursement and professional education strategies related to the already successful launch of the superion® indirect decompression system for the treatment of lumbar spinal stenosis mr enxing brings over  years of successful global leadership experience in product commercialization in the medical device spinal and chronic pain fields most recently michael served as vice president of sales at nevro corporation where he led the company to impressive growth both internationally and domestically over the previous four years prior to nevro he served as vice president of sales and marketing for vertos medical and has held various executive positions at cardiovascular systems inc fka cardio vascular solutions csi advanced neuromodulation systems inc acquired by st jude medical inc stryker corporation and tecnol medical products inc acquired by kimberly clark  michael is a graduate of iowa state university with a bs in communications and focus in business administration earl r fender president  chief executive officer of vertiflex said “we are very pleased to have attracted an executive of michael’s caliber into our organization michael is a visionary leader who understands sales and marketing execution market dynamics critical organizational metrics and cultural drivers that deliver team success and ensures the best customer engagement experiences possible we are confident that michael’s track record of significantly scaling businesses will add considerable value to vertiflex our investors physician providers and most of all to patients who will benefit from superion’s demonstrated and durable clinical and safety profile” mr enxing said “i’m proud to join the vertiflex team as a result of the company’s achievements in product development level i clinical evidence generation earning a pma approval and category i reimbursement for superion the stage is set to build a large high growth new category in spine that is focused on compelling clinical outcomes for patients and their physicians based on my prior experience in commercializing an early generation product for lumbar spinal stenosis i believe superion having significant published peerreviewed data is positioned as the bestinclass minimally invasive solution for lumbar spinal stenosis that will also compare well to open surgical decompression in treating patients suffering from lss” about vertiflex vertiflex is a privately held medical device company dedicated to the advancement of minimally invasive solutions for the treatment of lumbar spinal stenosis which is the leading cause of spinal surgery in the elderly founded in  and headquartered in carlsbad ca vertiflex has developed proprietary minimally invasive technologies for performing both indirect and direct decompressions of the lumbar spine these procedures fill the gap in the stenosis treatment continuum between conservative care and traditional spine surgery to date vertiflex has compiled the largest most rigorous body of device clinical evidence related to lumbar spinal stenosis for more information visit wwwvertiflexspinecom vertiflex inckathryn larson  9infovertiflexspinecom read at biospacecom related news vertiflex announces fda pma approval for the superion interspinous spacer retired celgene celg alum lands chairman gig at biotech guru ramaswamys dermavant mcra assists vertiflex with obtaining fda pma approval for the superion interspinous spacer system backed by google goog evelo bags  million and names some industry vets to the team vertiflex announces fda advisory panel support for the superion interspinous spacer why groupon’s cofounder is diving head first into healthcare fda postpones panel meeting for vertiflexs superion spine device court papers reveal astrazeneca plc azn ceo was livid over proteges defection to glaxosmithkline gsk vertiflex announces fda advisory panel meeting for the superion® interspinous spacer system effective immediately advaxis adxs ceo resigns interim leader named please enable javascript to view the comments powered by disqus comments powered by disqus • biospacecom • vertiflex   • biotechpharma  personnel                 vertiflex inc appoints michael enxing to vice president chief commercial officer  spine vertiflex inc appoints michael enxing to vice president chief commercial officer posted by josh sandberg on  weeks ago more in spine nuvasive announces new organizational structure to drive growth and profitability goals  hours ago camber spine technologies announces exceeding the th implantation of enza™ zeroprofile alif  hours ago web medical announces first us surgeries with d printed lateral spine truss system  hours ago share this story with your networkfacebooktwittergooglepinterestjuly   carlsbad calif–business wire–vertiflex inc a leading innovator of advanced minimally invasive interventions for spinal stenosis today announced the appointment of michael enxing as vice president and chief commercial officer mr enxing will be responsible for leading all aspects of the company’s sales marketing health economicsreimbursement and professional education strategies related to the already successful launch of the superion® indirect decompression system for the treatment of lumbar spinal stenosis mr enxing brings over  years of successful global leadership experience in product commercialization in the medical device spinal and chronic pain fields most recently michael served as vice president of sales at nevro corporation where he led the company to impressive growth both internationally and domestically over the previous four years prior to nevro he served as vice president of sales and marketing for vertos medical and has held various executive positions at cardiovascular systems inc fka cardio vascular solutions csi advanced neuromodulation systems inc acquired by st jude medical inc stryker corporation and tecnol medical products inc acquired by kimberly clark  michael is a graduate of iowa state university with a bs in communications and focus in business administration earl r fender president  chief executive officer of vertiflex said “we are very pleased to have attracted an executive of michael’s caliber into our organization michael is a visionary leader who understands sales and marketing execution market dynamics critical organizational metrics and cultural drivers that deliver team success and ensures the best customer engagement experiences possible we are confident that michael’s track record of significantly scaling businesses will add considerable value to vertiflex our investors physician providers and most of all to patients who will benefit from superion’s demonstrated and durable clinical and safety profile” mr enxing said “i’m proud to join the vertiflex team as a result of the company’s achievements in product development level i clinical evidence generation earning a pma approval and category i reimbursement for superion the stage is set to build a large high growth new category in spine that is focused on compelling clinical outcomes for patients and their physicians based on my prior experience in commercializing an early generation product for lumbar spinal stenosis i believe superion having significant published peerreviewed data is positioned as the bestinclass minimally invasive solution for lumbar spinal stenosis that will also compare well to open surgical decompression in treating patients suffering from lss” about vertiflex vertiflex is a privately held medical device company dedicated to the advancement of minimally invasive solutions for the treatment of lumbar spinal stenosis which is the leading cause of spinal surgery in the elderly founded in  and headquartered in carlsbad ca vertiflex has developed proprietary minimally invasive technologies for performing both indirect and direct decompressions of the lumbar spine these procedures fill the gap in the stenosis treatment continuum between conservative care and traditional spine surgery to date vertiflex has compiled the largest most rigorous body of device clinical evidence related to lumbar spinal stenosis for more information visit wwwvertiflexspinecom contacts vertiflex inc kathryn larson  9 infovertiflexspinecom leave a comment cancel your email address will not be published required fields are marked message name  email address  website notify me of followup comments by email notify me of new posts by email recent exactech q revenue  million on continuing strong extremities revenuenuvasive reports second quarter  financial resultsnuvasive announces new organizational structure to drive growth and profitability goalsglobal orthobiologics market forecast camber spine technologies announces exceeding the th implantation of enza™ zeroprofile alifpopular the single protein injection which could replace the need for knee surgery for osteoarthritis sufferers  comments pegasus biologics is insolvent closing their doors  comments the spineblogger  comments nuvasive ceo no sign of economic hit to spinal devices  comments win an ipod shuffle  comments tweets my tweets follow us lets connect on any of these social networks subscribe to blog via email enter your email address to subscribe to this blog and receive notifications of new posts by email email address polls with the acquisition of spinal elements what do you expect to be the fate of amendia file for ipo get acquired struggle to integrate  grow status quo increased growth but stay private view results  loading  polls archive orthospinenews michael enxing of nevro corp executive profile   nevro corp  nvro overviewexecutive compensationinsider activitykey executivesboard of directorscommittees key executives  michael enxing michael enxing vice president sales profile connections biography michael enxing has served as our vice president of sales since december  from 9 to december  mr enxing served as vice president of vertos medical inc a medical device company from 9 to 9 mr enxing held various executive positions at cardiovascular systems inc fka cardio vascular solutions csi a medical device company advanced neuromodulation systems inc acquired by st jude medical a medical device company stryker corporation a medical technology company and tecnol medical products inc acquired by kimberly clark a medical device company mr enxing is a graduate of iowa state university with a bs in communications and focus in business administration board membership michael enxing is not a member of any boards   michael enxing vice president and coo vertiflex timesjavascript is disabled market profiles login sign up login sign up   edit person michael enxing vice president and coo at vertiflex location san francisco bay area add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop michael enxing vice president and coo at vertiflex location san francisco bay area add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop michael enxing joined nevro in  and serves as vice president of sales and marketing of the company from 9 to december  mr enxing served as vice president of vertos medical inc a medical device company from 9 to 9 mr enxing held various executive positions at cardiovascular systems inc fka cardio vascular solutions csi a medical device company advanced neuromodulation systems inc acquired by st jude medical inc a medical device company stryker corporation a medical technology company and tecnol medical products inc acquired by kimberly clark a medical device company mr enxing is a graduate of iowa state university with a bs in communications and focus in business administration  companies in career na related markets  colleagues na related investments alias na industry medical device equipment supplies manufacturing tags spine neurology surgeons topics of influence na na careers achievements investments related people edit view all michael enxingcareer  jul vertiflex vice president and coo dec to jul nevro global vice president of sales and marketing mar9 to nov vertos medical vice president of sales  to 9 cardiovascular systems sales director  to  st jude medical director of sales 9 to  stryker director competencies edit view all michael enxingeducation 99 iowa state university speech communications edit michael enxingachievements and recognitions add milestone no milestones has been recorded for michael enxing edit michael enxinglinks add link no links has been recorded for michael enxing michael enxinginvestmentsacquisitions no investments has been recorded for michael enxing michael enxinginvestments representing others no investment reps has been recorded for michael enxing michael enxingrelated people colleagues at vertiflex j p timm vice president operations and development feb kathryn larson senior director global strategic marketing feb shane johnson vice president of sales feb earl fender president  ceo mar view all michael enxingrecommended market profiles  telemedicine  or more employees  companies social media marketing chiefmarteccom    employees  companies big data universe list of lists  or more employees  companies aggregated marketing technology  or more employees  companies shared economy landscape jeremiah owyang  or more employees  companies inside sales landscape  or more employees  companies vertiflex inc appoints michael enxing to vice president chief commercial officerhomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets close in  hrs  minssp 99 dow 9 stocks to watchintel impresses with strong quarter starbucks and mattel shares are tankingvertiflex inc appoints michael enxing to vice president chief commercial officerbusiness wirejuly  reblogsharetweetsharecarlsbad califbusiness wirevertiflex inc a leading innovator of advanced minimally invasive interventions for spinal stenosis today announced the appointment of michael enxing as vice president and chief commercial officer mr enxing will be responsible for leading all aspects of the company’s sales marketing health economicsreimbursement and professional education strategies related to the already successful launch of the superion® indirect decompression system for the treatment of lumbar spinal stenosismr enxing brings over  years of successful global leadership experience in product commercialization in the medical device spinal and chronic pain fields most recently michael served as vice president of sales at nevro corporation where he led the company to impressive growth both internationally and domestically over the previous four years prior to nevro he served as vice president of sales and marketing for vertos medical and has held various executive positions at cardiovascular systems inc fka cardio vascular solutions csi advanced neuromodulation systems inc acquired by st jude medical inc stryker corporation and tecnol medical products inc acquired by kimberly clark  michael is a graduate of iowa state university with a bs in communications and focus in business administrationearl r fender president  chief executive officer of vertiflex said “we are very pleased to have attracted an executive of michael’s caliber into our organization michael is a visionary leader who understands sales and marketing execution market dynamics critical organizational metrics and cultural drivers that deliver team success and ensures the best customer engagement experiences possible we are confident that michael’s track record of significantly scaling businesses will add considerable value to vertiflex our investors physician providers and most of all to patients who will benefit from superion’s demonstrated and durable clinical and safety profile”mr enxing said “i’m proud to join the vertiflex team as a result of the company’s achievements in product development level i clinical evidence generation earning a pma approval and category i reimbursement for superion the stage is set to build a large high growth new category in spine that is focused on compelling clinical outcomes for patients and their physicians based on my prior experience in commercializing an early generation product for lumbar spinal stenosis i believe superion having significant published peerreviewed data is positioned as the bestinclass minimally invasive solution for lumbar spinal stenosis that will also compare well to open surgical decompression in treating patients suffering from lss”about vertiflexvertiflex is a privately held medical device company dedicated to the advancement of minimally invasive solutions for the treatment of lumbar spinal stenosis which is the leading cause of spinal surgery in the elderly founded in  and headquartered in carlsbad ca vertiflex has developed proprietary minimally invasive technologies for performing both indirect and direct decompressions of the lumbar spine these procedures fill the gap in the stenosis treatment continuum between conservative care and traditional spine surgery to date vertiflex has compiled the largest most rigorous body of device clinical evidence related to lumbar spinal stenosis for more information visit wwwvertiflexspinecomview source version on businesswirecom httpwwwbusinesswirecomnewshomeenreblogsharetweetsharerecently viewedyour list is emptywhat to read nextvirgin atlantic founder sir richard branson sells pc stake in airline for £m as part of new tieup with air franceklmthe telegraphengineer finds pattern makes millions in stocksmoney morningsponsoredflights to hawaii are about to get so much cheaperrefinery9tax cuts just got more likelyyahoo financetrump’s unwitting legacy could be universal health coverageyahoo financezuckerberg wifes ambitious secret finally exposedunewzmesponsoredintel impresses with strong quarter starbucks and mattel shares are tankingyahoo financeblue apron gets some bullish callsyahoo finance videothe real reason overseas manufacturing is coming to americayahoo financewomen need to carry this device with themsiren songsponsoredsean hannity responds to claim he ran up a  tab at trumps hotel after flying in a yearold lobster from mainebusiness insiderairbnb sued by woman who says she was sexually assaulted by superhostthe guardianthe government cant help people from making the singlebiggest investing mistakeyahoo financediscover it  out of  avg by k customersdiscover cardsponsoredpogue the business of keeping  kitchens out of landfillsyahoo finance videotodays charts dont get blindsided by teslas shiny new model yahoo financetrump headed to long island to trumpet ms crackdownftheworld kill them all dont detain them and waste tax payers money criminals must be terminatedjoin the conversation  k